Most Recent Articles about DHR
https://www.zacks.com/stock/news/2246601/wall-street-analysts-see-danaher-dhr-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2246601
Mar 27, 2024 - According to the average brokerage recommendation (ABR), one should invest in Danaher (DHR). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
zc:1743433975262545632
0
https://www.zacks.com/stock/news/2243768/danaher-dhr-stock-declines-while-market-improves-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2243768
Mar 20, 2024 - The latest trading day saw Danaher (DHR) settling at $251.68, representing a -0.81% change from its previous close.
zc:-2426301587910424418
0
https://www.zacks.com/stock/news/2240039/danaher-dhr-benefits-from-business-strength-amid-risks?cid=CS-ZC-FT-analyst_blog|zer_report_update-2240039
Mar 13, 2024 - Danaher (DHR) gains from strength in academic and life science research markets, Abcam buyout and pro-investor policies. However, softness in its Biotechnology and Diagnostics units is concerning.
zc:-2502762979054578943
0